Stereotaxis, Inc.

US$1.09As of Sun 8 Nov 2026, 12:00 UTC
AMEX:STXSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 4.52%
Div yield —
ROE (184.27%)
Medical Instruments & Supplies
Beta (5Y) 1.40
PE TTM —
TSR TTM (62.54%)
Mkt cap US$109.2M
ROIC (69.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.27
16.43%
48.01%
Buy 10|7|6|1|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
24.03%
28.42%
25.00%
28.42%
Revenue$M
12.66
12.64
12.47
12.68
6.04%
3.75%
(1.35%)
3.32%
Peers (US$109.2M)
Cap (US$)
PE
202.1M
17.37x
108.6M
9.067x
Capital
TTM
5Y
10Y
Leveragex
5.034
(0.278)
(0.257)
EBIT/Intx
1.087
0.602
0.418
Own earn%
25.41
(73.59)
(66.79)
Sh yield%
14.37
24.44
27.06
Owners
Insiders/Inst%
11.65
58.40
Short interest%
4.61
SBC / revenue%
2.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
25–31
$1 testx
—
Incr. ROIC%
1